Fundraising Fox

Biotech Investors & VC Firms in Europe

204 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.

Nina Capital
BarcelonaPre-Seed–Series A$216K – $1.6M
6 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
9 people
Wallonie Entreprendre
LiégeSeed–Late Stage
9 people
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
Crista Galli Ventures
LondonSeed–Series A
2 people
TCG Crossover
Palo AltoSeed–Late Stage
8 people
+ND Capital
WoodsideSeed–Late Stage$540K – $5.4M
5 people
AMR Action Fund
BostonSeed–Series B
8 people
Backed
LondonSeed$540K – $2.7M
5 people
Clay Capital
Seed–Late Stage$3M – $8M
5 people
Debiopharm Innovation Fund
LausanneSeries A–Late Stage$3M – $5M
5 people
Delta Partners
DublinSeed–Series A$108K – $3.2M
5 people
HEARTFELT_
BerlinPre-Seed–Series A
8 people
Innovation Nest
KrakowSeed–Series A$108K – $1.1M
5 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
5 people
Neulogy Ventures
BratislavaSeed–Series A$216K – $3.2M
5 people
Practica Capital
VilniusPre-Seed–Series A$324K – $3.2M
5 people
Pureos Bioventures
PfäffikonSeed–Series A
8 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Seventure Partners
ParisSeed–Series B
AdBio partners
ParisSeed–Series A
7 people
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Brunnur Ventures GP
ReykjavíkSeed–Series A$1M – $3M
4 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.